Application note: Integrated biologics – Enabling high-throughput drug discovery at Amgen with Thermo Fisher™ Platform for Science™ Software
Posted: 29 November 2018 | Thermo Fisher Scientfic | No comments yet
Every day scientists are working to discover and develop new therapies and treatments to change the lives of patients suffering from serious and debilitating illnesses. Amgen Inc. has made it a priority to unlock the potential of biology to discover, develop, manufacture, and deliver innovative therapeutics to patients.
Please complete the form below in order to download this application note:
Related content from this organisation
- Using integrative biophysical approaches to understand GPCR regulation by β-arrestins
- Synthetic biology is ready for the therapeutic limelight
- Advancing novel biotherapeutics based on synthetic biology
- Global high-content screening market set to be worth $2.52bn by 2030
- Application note: Advancing CAR T-cell therapy with CTS TrueCut Cas9 Protein
Related topics
Bioinformatics, Biologics, Biopharmaceuticals, Disease Research, DNA, Drug Discovery, Drug Discovery Processes, Informatics, Research & Development, Therapeutics
Related organisations
Amgen, Thermo Fisher Scientific
